Attenuation of Microglial Activation and Pyroptosis by Inhibition of P2X7 Pathway Promotes Photoreceptor Survival in

Manjing Cao1,2, Xinting Huang3, Jingling Zou3

  • 1Department of Ophthalmology, Shanghai General Hospital (Shanghai First People's Hospital), Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Abstract

Insights

Extracellular ATP triggers P2X7 receptor activation in retinal detachment, causing microglial pyroptosis and photoreceptor death. Blocking P2X7 inhibits this process, offering a potential therapy for vision loss.

Area of Science:

  • Ophthalmology
  • Neuroscience
  • Immunology

Background:

  • Photoreceptor cell death is a primary cause of irreversible vision loss in retinal detachment (RD).
  • Microglial infiltration into the subretinal space (SRS) occurs after RD, but the mechanisms of microglial activation and their impact on photoreceptor survival are not fully understood.

Purpose of the Study:

  • To investigate the molecular mechanisms initiating microglial activation in retinal detachment.
  • To explore potential therapeutic strategies for promoting photoreceptor survival by targeting microglial activation.

Main Methods:

  • Developed a mouse model of retinal detachment (RD).
  • Measured extracellular adenosine triphosphate (ATP) levels and analyzed P2X7 receptor expression.
  • Assessed microglial activation, pyroptosis, and photoreceptor cell viability in vivo and in vitro.
  • Utilized a P2X7 antagonist (Brilliant Blue G) to evaluate therapeutic effects.

Main Results:

  • Extracellular ATP in the SRS after RD activates the P2X7 receptor, attracting microglia.
  • P2X7 activation triggers inflammasome signaling, leading to microglial pyroptosis and subsequent photoreceptor death.
  • Blocking P2X7 with Brilliant Blue G inhibited microglial activation and pyroptosis, preserving photoreceptor structure and function.

Conclusions:

  • ATP-induced P2X7-mediated microglial activation and pyroptosis contribute significantly to photoreceptor death in retinal detachment.
  • Inhibiting microglial pyroptosis presents a promising pharmacotherapeutic strategy for mitigating photoreceptor loss in RD.

Related Concept Videos